IP Archives of Cytology and Histopathology Research

Print ISSN: 2581-5725

Online ISSN: 2456-9267

CODEN : IACHCL

IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 622

PDF Downloaded: 232


Get Permission Tippani and Bachu: A case report: role of curative toilet mastectomy with latissimus dorsi flap recostruction in locally advanced breast cancer


Introduction

With 1.3 million new cases and almost half a million deaths annually, Breast Cancer is one of the most important health concerns Worldwide. In India Breast Cancer has ranked number one among females, with 25 -30% patients presenting as Locally Advanced Breast Cancer (LABC). The age adjusted rate is as high as 25.8/100,000 women and mortality is 1.27/100,000.1, 2, 3, 4, 5 However survival of patients with LABC is steadily improving with a decrease in death rate by 1-2% annually.6, 7

Locally Advanced Breast Cancer (LABC) is a heterogeneous group of tumors with varying clinical presentation such as presence of a large primary tumor or involvement of skin & chestwall or extensive regional lymph node involvement and absence of any evidence of metastasis. Some patients may have a rapid Neoplastic evolution where as others present with long history of tumor growth. Fungating malignant lesions are a subclass, presenting with large ulcerative growth which manifests with pain, disfigurement, hemorrhage, odor and infections. 8, 9, 10, 11, 12, 13, 14

Classification

Patients with stage IIB, III and IV of the TNM classification are included in LABC. In this Classification system patients are included if they have T3 or T4 tumors with any N stage or any T category with N2 or N3 or regional M1 involvement.15

Surgery is the main stay for LABC with NeoAdjuvant Chemotherapy followed by Radiotherapy. Toilet Mastectomy is an excellent adjunct to palliative care in LABC patients. This is useful for debulking of the tumor and for controlling infections and sepsis. The aim of the Palliative care is to improve the quality of life by controllimg infections and pain. 16, 17

Here we share our experience of a young patient with LABC presenting with fungating Breast Cancer which progressed on Chemotherapy.

Case History and Discussion

A young female patient of age 33 years presented with large fungating right breast mass with foul smell and discharge.

Past history

She was evaluated outside at a private hospital, where she was diagnosed as a Carcinoma of Breast and a trail of 2 cycles of NACT chemotherapy was given which showed progression of disease and patient was planned for supportive palliative care and sent home.

In view of young age of patient a palliative definitive Toilet Mastectomy was done after taking informed consent of patient and patient attendars, to increase the survival rate and give a benefit of cure. The raw area was closed with LD flap reconstruction.

Post operatively, patient recovered well and discharged. Further patient was given 8 cycles of Adjuvant chemotherapy treatment followed by 50gy of radiation to chest wall and supra clavicular area. After 3years of survival and follow up, patient is doing well.

CT scan of the chest with contrast revealed

Large irregular heterogeneously enhancing exophytic soft tissue density mass measuring 99×80mm.

Diffuse surrounding fatty inflammation is noted. The lesion is invading the skin causing thickening & large deep ulceration. Few Calcifications are noted within.

Posterior the lesion is noted abutting the Pectoralis muscle along the right lateral wall. Multiple heterogeneously enhancing nodules mass lesion in the right axillary region at level-I, II &III. Largest one measuring 53×49mm. Non enhancing hypo density lesion is noted within as Necrosis

CT scan of abdomen and pelvis (Plain & Contrast) is normal.

Histopathological examination

On gross examination Breast mass measuring 14.5×13.6×5.8cm covered with a skin flap measuring 10.5×10cm. Externally the skin flap shows a large ulcerated area measuring 10.5×8cm. Nipple areola identified separately from ulcerated area. Distance of nipple from ulcerated area is 0.8cm. Cut surface shows a lesion, which is a firm breast mass at right side measuring 8.6×6.5×5.2cm grey white, with occasional hemorrhagic areas is seen.

Level ll/lll axillary lymph nodes contain globular mass measuring 6.5×5×4cm. A cyst wall infiltration contains grey white-grey brown soft tissue measuring 2.5×2×0.3cm.

Microscopic examination shows extensive areas of necrosis with viable lesion predominantly composed of large polygonal cells arranged around the vessels. There is marked nuclear pleomorphism. Lobules of cartilage with atypical cells are seen in lacunae. Level II/III axillary lymphnode shows metastatic tumor deposits and Chest wall shows involvement of tumor. Histopathology report reveals Metaplastic Carcinoma with Chondrosarcomatous Differentiation-ypT4cN3aMx of right breast.

Histological grade

Nottingham Histologic score- Tubule differentiation-3

  1. Nuclear pleomorphism-3

  2. Mitosis figure -3

SBR Grade III

  1. Tumor focality- Unifocal

  2. Margins- separately sent superior& inferior margins including posterior surface are uninvolved

  3. Treatment effect in lymphnode- No definite response ion presurgical therapy in metastatic carcinoma

  4. Lymphovascular emboli- Present

  5. Extranodal extension- Present

Pathologic staging (pTNM)

  1. Primary tumor- ypT4c

  2. Regional lymph nodes- ypN3a (metastasis to level III axillary lymphnode)

  3. Distant Metastasis – ypMx

Immuno Histo Chemistry(IHC) Report

  1. ER—Negative

  2. PR—Negative

  3. Her2neu-- Negative

Figure 1

Pre operative image showing ulcerative fungative breast mass

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/6fe47567-9df6-40cf-8ef6-ac542c76fd1aimage1.png
Figure 2

Showing breast mass after surgery

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/6fe47567-9df6-40cf-8ef6-ac542c76fd1aimage2.png
Figure 3

a,b: Intra operative image showing the Axillary lymphnode

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/6fe47567-9df6-40cf-8ef6-ac542c76fd1aimage3.png
Figure 4

Shows raw area after lymphnode dissection

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/6fe47567-9df6-40cf-8ef6-ac542c76fd1aimage4.png
Figure 5

Shows large Axillary lymphnode mass

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/6fe47567-9df6-40cf-8ef6-ac542c76fd1aimage5.png

Conclusion

Based on the survival rate of greater than 3 years, a subset of young patients can be planned for palliative radical mastectomy with LD flap reconstruction.

Conflict of Interest

The authors declare that there is no conflict of interest.

Source of Funding

None.

References

1 

General Definition of Cancer. Medicine Net Home 2004

2 

P K Garg G Prakash Current definition of locally advanced breast cancerCurr Oncol2015225e4091010.3747/co.22.2697

3 

T Merz C Klein B Uebach M Kern C Ostgathe J Bükki Fungating wounds-multidimensional challenge in palliative careBreast Care20116

4 

F Bray J Ferlay I Soerjomataram R L Siegel L A Torre A Jemal Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin2018686394424

5 

S Malvia S A Bagadi U S Dubey S Saxena Epidemiology of breast cancer in Indian womenAsia Pac J Clin Oncol20171342899510.1111/ajco.12661

6 

V V Valero A U Buzdar G N Hortobagyi Locally advanced breast cancerOncologist199611 & 2817

7 

F Andre K Slimane T Bachelot Breast cancer with synchronous metas­tases: Trends in survival during a 14-year periodJ Clin Oncol2004221633028

8 

S H Giordano A U Buzdar T L Smith SW Kau Y Yang GN Hortobagyi Is breast cancer survival improv­ing? Cancer20041001445210.1002/cncr.11859

9 

GN Hortobagyi GR Blumenschein W Spanos ED Montague AU Buzdar HY Yap Multimodal treatment of locoregionally advanced breast cancerCurr Oncol1983515763810.1002/1097-0142(19830301)51:5<763::aid-cncr2820510502>3.0.co;2-c

10 

T Merz C Klein B Uebach M Kern C Ostgathe J Bükki Fungating wounds-multidimensional challenge in palliative careBreast Care (Basel)20116121410.1159/000324923

11 

E Davila C L Vogel Management of locally advanced breastcancer (stage III): a reviewInt Adv Surg Oncol19847297327

12 

GN Hortobagyi FC Ames AU Buzdar SW Kau MD McNeese D Paulus Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer1988621225071610.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d

13 

G N Hortobagyi A U Buzdar J Ragaz IM Ariel Locally advanced breast cancer: a review including the M.D. Anderson experienceHigh-Risk Breast Cancer—TherapySpringer-Verlag1991382415

14 

G N Hortobagyi Multidisciplinary management of advanced primary and metastatic breast cancerCancer19947414162310.1002/cncr.2820741329

15 

I A Jaiyesimi A U Buzdar G Hortobagyi Inflammatory breast cancer: a reviewJ Clin Oncol199210610142410.1200/JCO.1992.10.6.1014

16 

FC Brunicardi Schwartz’s Principles of Surgery. 9th ed.Mc Graw Hill2010

17 

JE Fischer Mastery of Surgery 5th edn.Lippincott Williams & Wilkins2007416



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Case Report


Article page

71-74


Authors Details

Avinash Tippani, Brahmani Bachu


Article History

Received : 06-10-2021

Accepted : 14-02-2022


Article Metrics


View Article As

 


Downlaod Files